For his dumb ass supporters who actually believe that.
https://fortune.com/2020/11/09/pfizer-vaccine-funding-warp-speed-germany/
It’s said that success has many authors, and the encouraging data from Pfizer Inc.’s experimental COVID-19 vaccine had plenty of people in Washington lining up to take credit.
Vice President Mike Pence was among Trump administration officials saying support from the government’s Operation Warp Speed program helped accelerate the development of the vaccine, which was found to be more than 90% effective in preventing symptomatic COVID-19 infections in an interim analysis.
The truth is that Pfizer didn’t receive any funding from Operation Warp Speed for the development, clinical trial and manufacturing of the vaccine. Rather, its partner, BioNTech SE, has received money -- from the German government.
BioNTech is credited for contributing the messenger RNA technology, which prompts the body to make a key protein from the virus, creating an immune response. The biotechnology company already had a history of working with Pfizer on influenza vaccines, and in March they clinched a deal to co-develop a shot to prevent against COVID-19 at research sites both in the U.S. and Germany. The two companies began human testing of the vaccine in April, before the existence of Operation Warp Speed was revealed publicly.
Berlin gave the German company $445 million in an agreement in September to help accelerate the vaccine by building out manufacturing and development capacity in its home market.
Trump agreed to pay $2 billion for the vaccine. It's amazing what can be accomplished when a $2 billion purchase order is waiting for you.
Feds agree to buy 100 M doses of potential Pfizer vaccine

By
The Associated Press
July 22, 2020 8:28 am
1 min read
The U.S. will pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by Pfizer and its German partner BioNTech.
Shares of the U.S. drugmaker jumped 5% about an hour before the opening bell.
The U.S. government will receive the doses and make the payment after the drugmakers receive regulatory approval for a potential vaccine that has yet to start big clinical trials in humans. It also can acquire up to an additional 500 million doses, according to a statement released Wednesday by the drugmakers.
The companies announced earlier this month that the first of four experimental vaccines they are testing showed encouraging results in very early testing of 45 people.
Insight by DUO Security: State Department, NASA, OMB and Defense Manpower Data Center explore the future of identity, credential and access management in this free webinar.
The drugmakers aim to start a larger study focused on safety and effectiveness later this month. Depending on the results, the companies said they could seek some form of regulatory approval as early as October.
Nearly two dozen possible COVID-19 vaccines are in various stages of testing around the world. Different companies are pursuing different types of vaccines, boosting the odds that at least one approach might work — although there’s no guarantee.
Governments from several countries have agreed in advance to buy numerous options, to have them ready for use as soon as possible.
https://federalnewsnetwork.com/gove...-buy-100-m-doses-of-potential-pfizer-vaccine/